Trevi Therapeutics, Inc.
TRVIAs of the close on Sep 25, 2026
Price
$14.41
Market cap
$2.05B
P/E (diluted TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
EPS (TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Trevi Therapeutics, Inc. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 8 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 4, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| PRUDENTIAL FINANCIAL INC | 2026-03-31 | 14,726 | Not shown | SEC filing |
| BNP PARIBAS FINANCIAL MARKETS | 2026-03-31 | 23,025 | Not shown | SEC filing |
| Optimize Financial Inc | 2026-03-31 | 31,890 | Not shown | SEC filing |
| OPPENHEIMER & CO INC | 2026-03-31 | 100,027 | Not shown | SEC filing |
| FIFTH THIRD BANCORP | 2026-03-31 | 128,325 | Not shown | SEC filing |
| Police & Firemen's Retirement System of New Jersey | 2026-03-31 | 23,777 | Not shown | SEC filing |
| PEREGRINE CAPITAL MANAGEMENT LLC | 2026-03-31 | 530,451 | Not shown | SEC filing |
| Rubric Capital Management LP | 2026-03-31 | 3,712,373 | Not shown | SEC filing |
| State of New Jersey Common Pension Fund D | 2026-03-31 | 29,133 | Not shown | SEC filing |
| Vestal Point Capital, LP | 2026-03-31 | 2,166,504 | Not shown | SEC filing |
| BARCLAYS PLC | 2026-03-31 | 53,585 | Not shown | SEC filing |
| Avidity Partners Management LP | 2026-03-31 | 6,660 | Not shown | SEC filing |
| Invesco Ltd. | 2026-03-31 | 352,984 | Not shown | SEC filing |
| Keating Financial Advisory Services, Inc. | 2026-03-31 | 1 | Not shown | SEC filing |
| XTX Topco Ltd | 2026-03-31 | 24,735 | Not shown | SEC filing |
| Siren, L.L.C. | 2026-03-31 | 1,786,867 | Not shown | SEC filing |
| Universal- Beteiligungs- und Servicegesellschaft mbH | 2026-03-31 | 36,464 | Not shown | SEC filing |
| Harbour Capital Advisors, LLC | 2026-03-31 | 40,700 | Not shown | SEC filing |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2026-03-31 | 840,572 | Not shown | SEC filing |
| Optiver Holding B.V. | 2026-03-31 | 666 | Not shown | SEC filing |
- Each value is checked against Trevi Therapeutics, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 20 rows: no share price from within three months of their report dates is on file, so they could not be checked.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Trevi Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-03-10 · Simon Farrell: Larger than 31 of the 33 other insider sales of Common Stock on file. SEC filing
- 2022-07-05 · BONDERMAN DAVID: Larger than 30 of the 33 other insider sales of Common Stock on file. SEC filing
- 2022-07-01 · BONDERMAN DAVID: Larger than all 33 other insider sales of Common Stock on file. SEC filing
- 2022-06-30 · BONDERMAN DAVID: Larger than 32 of the 33 other insider sales of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2022-04-11–2022-04-11: 7 event(s) across 7 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing )
- 2022-04-11–2022-04-11: 16 event(s) across 9 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing )
- 2021-10-18–2021-10-18: 9 event(s) across 9 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing , filing , filing )
- 2021-10-18–2021-10-18: 9 event(s) across 9 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing , filing , filing )
- 2021-10-18–2021-10-18: 9 event(s) across 9 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2025-03-25 | SCIASCIA THOMAS · Chief Scientific Officer | Common Stock | S — Open market or private sale | −2,631 | 6.60 | SEC filing |
| 2025-03-21 | GOOD JENNIFER L · President & CEO | Common Stock | S — Open market or private sale | −5,263 | 6.58 | SEC filing |
| 2025-03-10 | Simon Farrell · Chief Commercial Officer | Common Stock | S — Open market or private sale | −76,963 | 6.73 | SEC filing |
| 2025-03-10 | Simon Farrell · Chief Commercial Officer | Common Stock | S — Open market or private sale | −4,350 | 7.15 | SEC filing |
| 2024-09-09 | GOOD JENNIFER L · President & CEO | Common Stock | S — Open market or private sale | −1,840 | 3.04 | SEC filing |
| 2024-09-06 | GOOD JENNIFER L · President & CEO | Common Stock | S — Open market or private sale | −4,219 | 3.03 | SEC filing |
| 2024-09-05 | GOOD JENNIFER L · President & CEO | Common Stock | S — Open market or private sale | −40,277 | 3.11 | SEC filing |
| 2024-09-04 | GOOD JENNIFER L · President & CEO | Common Stock | S — Open market or private sale | −10,981 | 3.02 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-03 | Mathers Edward T · Director | Nonstatutory Stock Option (right to buy) | A — Grant, award, or other acquisition | +35,000 | SEC filing |
| 2026-06-03 | Colangelo Dominick · Director | Nonstatutory Stock Option (right to buy) | A — Grant, award, or other acquisition | +35,000 | SEC filing |
| 2026-06-03 | VANLENT ANNE · Director | Nonstatutory Stock Option (right to buy) | A — Grant, award, or other acquisition | +35,000 | SEC filing |
| 2026-06-03 | Heffernan Michael Thomas · Director | Nonstatutory Stock Option (right to buy) | A — Grant, award, or other acquisition | +35,000 | SEC filing |
| 2026-06-03 | Meeker David P · Director | Nonstatutory Stock Option (right to buy) | A — Grant, award, or other acquisition | +35,000 | SEC filing |
| 2026-02-19 | Simon Farrell · Chief Commercial Officer | Stock Option (right to buy) | A — Grant, award, or other acquisition | +160,000 | SEC filing |
| 2026-02-19 | Galletta Christopher · See Remarks | Stock Option (right to buy) | A — Grant, award, or other acquisition | +35,000 | SEC filing |
| 2026-02-19 | SCIASCIA THOMAS · Chief Scientific Officer | Stock Option (right to buy) | A — Grant, award, or other acquisition | +85,000 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.